MedTech News
.................... by Andrew Celentano
BPS Bioscience Licenses Monod Bio’s AI-Designed Proteins to Develop Novel Research Products and Services
SEATTLE and SAN DIEGO, Oct. 8, 2026 /PRNewswire/ — Monod Bio and BPS Bioscience today announced a non-exclusive licensing agreement covering Monod Bio’s LuxSit Pro de novo luciferase and NovoBody binding proteins. BPS plans to integrate the technologies into the development of innovative research products and services for drug discovery and life science applications.
ClaroNav Kolahi Receives EU MDR Certification for Navient Surgical Navigation System
ClaroNav Kolahi has received certification under the European Union Medical Device Regulation (MDR) for its Navient Surgical Navigation System, covering the Navient Image Guided Navigation System and its reusable surgical instruments, allowing the company to continue offering Navient throughout the European Union under the EU MDR regulatory framework.
CraniUS Therapeutics Secures Second FDA 510(k) Clearance in Six Weeks and Earns U.S. Patent for NeuroPASS™ 3 Cranial Drug Delivery System
Newly cleared CraniUS® Plate configuration, designated NeuroPASS 2, adds an opening designed to accommodate an implantable intracranial pressure sensor; issued patent protects the integrated drug delivery architecture at the heart of NeuroPASS 3.
True Indicating Announces FDA Clearance of InstaTRU™, an Instant Biological Indicator for Steam Sterilization Cycles
TOLEDO, Ohio, Oct. 7, 2026 /PRNewswire/ — True Indicating, LLC today announced they received FDA clearance of InstaTRU™, an instant biological indicator for steam sterilization cycles that provides results in just 20 seconds. Using spore-based technology, InstaTRU™ confirms the efficacy of a steam sterilization cycle without requiring an incubator or reader.
Of mice and zebrafish: How scientists solved a decades-old mystery and uncovered new insights about inflammation
Their new study, published Oct. 7 in Nature, solves a decades-old scientific puzzle and reveals that a critical inflammatory signaling pathway doesn’t just summon immune cells to the place where they’re needed—it also protects healthy cells from being damaged by the immune response.
‘Herd-Immunity-on-a-Chip’ recreates viral transmission within a simulated population
A research team led by Professor Sungsu Park of the School of Mechanical Engineering and Professor Byung Mook Weon of the School of Advanced Materials Science and Engineering at Sungkyunkwan University (SKKU) has developed a compact, centimeter-scale microfluidic “Herd-Immunity-on-a-Chip” platform that recreates key features of viral transmission in human societies within a controllable laboratory system.
Low-risk prostate tumors reveal molecular signs linked to more aggressive cancer
A new study revealed molecular features linked to more aggressive prostate cancer in a subset of patients who had been classified as low risk, highlighting biological differences that may not be apparent from clinical measures alone. The results could lead to new therapeutic strategies.
Experimental cancer treatment disrupts cell communication to suppress tumor growth in animal tests
A research team has developed an anticancer treatment platform that simultaneously targets cancer cells and the surrounding cells that support them while blocking communication between the two.